Plasma Levels of Fibronectin and Prostacyclin Metabolite in Peripartum Preeclamptic Women

Steve Calvin, Louis Weinstein, Marlys H. Witte, Paul R. Finley

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Plasma fibronectin and prostacyclin levels have been reported to vary in preeclamp-tic women when compared with pregnant control women. Elevation of fibronectin and deficiency of prostacyclin have been postulated to be due to endothelial cell disruption or dysfunction. Eighteen preeclamptic women and 19 normal pregnant controls were evaluated for plasma levels of fibronectin and the prostacyclin metabolite 6-keto-prosta-glandin F (6-keto-PGF). 6-keto-PGF and fibronectin plasma levels in patients were significantly different from control patients, with preeclamptic patients exceeding control subjects. Five patients had serial samples of 6-keto-PGF prior to, during, and after intravenous magnesium sulfate therapy and no consistent effect was noted. No correlation existed between fibronectin and 6-keto-PGF levels or between either compound and platelet count or liver function tests. Despite an overall elevation of fibronectin in preeclamptic patients, two patients with the hemolysis, elevated liver tests, and low platelet count syndrome showed low normal fibronectin levels coinciding with throm-bocytopenia, hemolysis, and liver dysfunction. The magnitude of fibronectin elevation may therefore not predict the severity of preeclampsia. The significance of these findings is discussed.

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalAmerican Journal of Perinatology
Volume7
Issue number2
DOIs
StatePublished - Apr 1990

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Plasma Levels of Fibronectin and Prostacyclin Metabolite in Peripartum Preeclamptic Women'. Together they form a unique fingerprint.

  • Cite this